Skip to main content
MyCapitol LogoMyCapitol

HR 9358 · 117th Congress

Access to Innovative Treatments Act of 2022

This bill creates a formal process for reviewing Medicare's decisions to deny or limit coverage of newly approved drugs and biologicals (medical treatments). Right now, when Medicare decides not to cover a new medication that the FDA has already approved, there's no clear way for patients, doctors, or drug manufactu…

Introduced
2022-11-29
Policy area
Health
Latest action
Referred to the Subcommittee on Health.

Digging through Congress... 🔍